Growth is expected through 2017, when the market reaches $9 billion, due to continued penetration of the population with cataracts (especially in emerging markets) as a result of efforts among national and international organizations to reduce blindness. Refractive surgeries will also contribute to revenue growth, although economic headwinds in key national markets will limit the performance of these procedures.
Other key trends, including pricing in local markets and product mix, will have key effects on competitive shares and product adoption. Critical issues covered in this report include:
1. EXECUTIVE SUMMARY 1.1 The Global Market by Region 1.2 The Global Market by Product Segment 1.2.1 Competitive Analysis Exhibit 1-1: Global Market Forecast for Surgical Ophthalmology Products, 2009-2017 Exhibit 1-2: Global Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017 Exhibit 1-3: Global Market Forecast for Surgical Ophthalmology Products by Region, 2009-2017 Exhibit 1-4: Global Market Forecast for Surgical Ophthalmology Products by Product Type, 2009-2017 Exhibit 1-5: Global Supplier Shares, 2011 & 2012 2. OVERVIEW 2.1 Anatomy of the Human Eye 2.2 Blindness and Low Vision 2.3 Cataract Surgery 2.3.1 Phacoemulsification 2.3.2 Extracapsular Cataract Extraction 2.3.3 Intracapsular Cataract Extraction 2.4 Glaucoma Surgery 2.4.1 Surgeries to Reduce Production of Aqueous Humour 2.4.2 Surgeries to Improve the Flow of Aqueous Humour 2.4.2.1 Filtering Procedures 2.4.2.1.1 Penetrating Filtering Procedures 2.4.2.1.2 Non-Penetrating Filtering Procedures 2.4.2.2 Laser Trabeculoplasty 2.4.2.3 Iridotomy 2.4.2.4 Iridectomy 2.4.2.5 Glaucoma Implants 2.5 Vitreoretinal Surgery 2.6 Refractive Surgery 2.6.1 Flap Procedures 2.6.2 Surface Procedures 2.6.3 Corneal Incision Procedures 2.6.4 Phakic IOL Implantation Exhibit 2-1: General Types of Surgical Procedures for the Human Eye Exhibit 2-2: The Human Eye Exhibit 2-3: Causes of Blindness by Race/Ethnicity in the U.S., 2004 Exhibit 2-4: Causes of Low Vision by Race/Ethnicity in the U.S., 2004 Exhibit 2-5: Types of Glaucoma 3. OPHTHALMIC DIAGNOSTIC DEVICES 3.1 Slit Lamps 3.2 Ocular Tonometers 3.3 Corneal Pachymeters 3.4 Optical Coherence Tomography 3.5 Optical Biometers 3.6 Scanning Laser Polarimeters 3.7 Fundus Cameras 3.8 Wavefront Aberrometers Exhibit 3-1: Selected Slit Lamps Exhibit 3-2: Ocular Tonometry Methods Exhibit 3-3: Selected Clinical Studies that Examine the Effectiveness of Various Methods of Ocular Tonometry Exhibit 3-4: Selected Optical Tonometers Exhibit 3-5: Selected Clinical Studies that Examine the Effectiveness of Ultrasound Corneal Pachymetry Exhibit 3-6: Selected Ultrasound Corneal Pachymeters Exhibit 3-7: Selected Clinical Studies that Examine the Effectiveness of Optical Coherence Tomography Exhibit 3-8: Selected Optical Coherence Tomography Imaging Systems Exhibit 3-9: Selected Clinical Studies that Examine the Effectiveness of Optical Biometers Exhibit 3-10: Selected Biometry Systems Exhibit 3-11: Selected Clinical Studies that Examine the Effectiveness of Scanning Laser Polarimetry Exhibit 3-12: Selected Fundus Photography and Imaging Systems Exhibit 3-13: Selected Clinical Studies that Examine the Effectiveness of Wavefront Aberrometry Exhibit 3-14: Selected Wavefront Systems or Aberrometers 4. OPHTHALMIC SURGICAL SYSTEMS 4.1 Phacoemulsification Systems 4.1.1 Clinical Studies 4.1.2 Companies and Products 4.2 Ophthalmic Laser Systems 4.2.1 Clinical Studies 4.2.2 Companies and Products 4.2.2.1 Photocoagulating Lasers 4.2.2.2 Photodisrupting Lasers 4.2.2.3 Photoablating Lasers 4.2.2.4 Femtosecond Lasers 4.2.2.5 Combination or Multi-Modal Lasers Exhibit 4-1: Selected Clinical Studies on the Effectiveness of Phacoemulsification Exhibit 4-2: Selected Phacoemulsification Systems Exhibit 4-3: Selected Clinical Studies on the Effectiveness of Ophthalmic Laser Systems Exhibit 4-4: Selected Photocoagulating Laser Systems Exhibit 4-5: Selected Photodisrupting Laser Systems Exhibit 4-6: Selected Photoablating Laser Systems Exhibit 4-7: Selected Femtosecond Lasers Exhibit 4-8: Selected Multi-Modality Laser Systems 5. IMPLANTS AND DISPOSABLES 5.1 Intraocular Lenses 5.1.1 Clinical Results 5.1.2 Companies and Products 5.1.2.1 Monofocal Vs. Multifocal 5.1.2.2 Phakic vs. Aphakic IOLs 5.1.2.3 Other Types of IOLs 5.1.2.4 IOL Injectors or Insertion Instruments 5.1.2.5 Disposable Supplies and Accessories 5.2 Glaucoma Implants 5.2.1 Clinical Results 5.2.2 Companies and Products Exhibit 5-1: Selected Clinical Studies on the Effectiveness of IOL Implantation Exhibit 5-2: Selected Monofocal Intraocular Lenses Exhibit 5-3: Selected Multifocal Intraocular Lenses Exhibit 5-4: Selected Toric Intraocular Lenses Exhibit 5-5: Selected Accommodating Intraocular Lenses Exhibit 5-6: Selected Phakic Intraocular Lenses Exhibit 5-7: Selected Preloaded IOL Insertion Instruments Exhibit 5-8: Selected Disposable IOL Insertion Instruments Exhibit 5-9: Selected Reusable IOL Insertion Instruments Exhibit 5-10: Selected IOL Cartridges Exhibit 5-11: Selected Ophthalmic Viscoelastic Devices and Other Solutions Exhibit 5-12: Selected Supplies and Accessories Exhibit 5-13: Selected Clinical Studies on the Effectiveness of Glaucoma Implants Exhibit 5-14: Selected Glaucoma Implants Exhibit 5-15: Selected Glaucoma Supplies and Accessories 6. PROCEDURE VOLUMES AND MARKET FORECASTS 6.1 Global Procedure Volumes 6.2 Global Market Analysis 6.3 Competitive Analysis 6.4 Regional Analysis 6.4.1 The United States 6.4.1.1 Procedure Volumes 6.4.1.2 Market Analysis 6.4.1.3 Competitive Analysis 6.4.2 Europe 6.4.2.1 Procedure Volumes 6.4.2.2 Market Analysis 6.4.3 AP & ROW 6.4.3.1 Procedure Volumes 6.4.3.2 Market Analysis 6.4.3.3 OUS Competitive Analysis Exhibit 6-1: Global Burden of Blindness, Partial Sight, and Cataracts, 2009-2017 Exhibit 6-2: Global Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017 Exhibit 6-3: Cataract Procedure Volumes by Region, 2009-2017 Exhibit 6-4: Refractive Eye Surgery, Procedure Volumes by Region, 2009-2017 Exhibit 6-5: Global Market Forecast for Surgical Ophthalmology Products by Product Type, 2009-2017 Exhibit 6-6: Global Market Forecast for Surgical Ophthalmology Products by Region, 2009-2017 Exhibit 6-7: Global Supplier Shares, 2011 & 2012 Exhibit 6-8: U.S. Burden of Blindness, Partial Sight, and Cataracts, 2009-2017 Exhibit 6-9: U.S. Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017 Exhibit 6-10: Cataract Procedure Volumes in the U.S., 2009-2017 Exhibit 6-11: Refractive Surgery Volumes in the U.S., 2009-2017 Exhibit 6-12: Phacoemulsification Procedure Volumes in the U.S., 2009-2017 Exhibit 6-13: Cataract IOL Implantations in the U.S., 2009-2017 Exhibit 6-14: Surgical Ophthalmology Products, U.S. Market Forecast, 2009-2017 Exhibit 6-15: Ophthalmic Surgical Systems by Type, U.S. Market Forecast, 2009-2017 Exhibit 6-16: U.S. Market Forecast for Phacoemulsification, 2009-2017 Exhibit 6-17: U.S. Market Forecast for Phacoemulsification: Systems, Accessories, and Service, 2009-2017 Exhibit 6-18: U.S. Market Forecast for Refractive Laser Systems, 2009-2017 Exhibit 6-19: U.S. Market Forecast for Refractive Laser Systems: Systems, Accessories, and Service, 2009-2017 Exhibit 6-20: U.S. Market Forecast for Licensing Fees Associated with Refractive Laser Systems, 2009-2017 Exhibit 6-21: U.S. Market Forecast for Implants and Disposables by Type, 2009-2017 Exhibit 6-22: U.S. Market Forecast for Cataract IOLs, 2009-2017 Exhibit 6-23: U.S. Market Forecast for Ophthalmic Viscosurgical Devices, 2009-2017 Exhibit 6-24: U.S. Market Forecast for Phakic IOLs, 2009-2017 Exhibit 6-25: U.S. Market Forecast for Diagnostic Ophthalmic Systems, 2009-2017 Exhibit 6-26: U.S. Supplier Shares for Cataract IOLs, 2011 and 2012 Exhibit 6-27: U.S. Supplier Shares for Other Cataract Surgical Products, 2011 and 2012 Exhibit 6-28: U.S. Supplier Shares for Refractive Surgery Products, 2011 and 2012 Exhibit 6-29: U.S. Supplier Shares for Ophthalmic Diagnostic Systems, 2011 and 2012 Exhibit 6-30: European Burden of Blindness, Partial Sight, and Cataracts, 2009-2017 Exhibit 6-31: European Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017 Exhibit 6-32: Cataract Procedure Volumes in Europe, 2009-2017 Exhibit 6-33: Refractive Surgery Volumes in Europe, 2009-2017 Exhibit 6-34: Phacoemulsification Procedure Volumes in Europe, 2009-2017 Exhibit 6-35: Cataract IOL Implantations in Europe, 2009-2017 Exhibit 6-36: Surgical Ophthalmology Products, European Market Forecast, 2009-2017 Exhibit 6-37: Ophthalmic Surgical Systems by Type, European Market Forecast, 2009-2017 Exhibit 6-38: European Market Forecast for Phacoemulsification, 2009-2017 Exhibit 6-39: European Market Forecast for Phacoemulsification: Systems, Accessories, and Service, 2009-2017 Exhibit 6-40: European Market Forecast for Refractive Laser Systems, 2009-2017 Exhibit 6-41: European Market Forecast for Refractive Laser Systems: Systems, Accessories, and Service, 2009-2017 Exhibit 6-42: European Market Forecast for Licensing Fees Associated with Refractive Laser Systems, 2009-2017 Exhibit 6-43: European Market Forecast for Implants and Disposables by Type, 2009-2017 Exhibit 6-44: European Market Forecast for Cataract IOLs, 2009-2017 Exhibit 6-45: European Market Forecast for Ophthalmic Viscosurgical Devices, 2009-2017 Exhibit 6-46: European Market Forecast for Phakic IOLs, 2009-2017 Exhibit 6-47: European Market Forecast for Diagnostic Ophthalmic Systems, 2009-2017 Exhibit 6-48: AP & ROW Burden of Blindness, Partial Sight, and Cataracts, 2009-2017 Exhibit 6-49: AP & ROW Burden of Blindness, Partial Sight, and Cataracts by Type, 2009-2017 Exhibit 6-50: Cataract Procedure Volumes in AP & ROW, 2009-2017 Exhibit 6-51: Refractive Surgery Volumes in AP & ROW, 2009-2017 Exhibit 6-52: Phacoemulsification Procedure Volumes in AP & ROW, 2009-2017 Exhibit 6-53: Cataract IOL Implantations in AP & ROW, 2009-2017 Exhibit 6-54: Surgical Ophthalmology Products, AP & ROW Market Forecast, 2009-2017 Exhibit 6-55: Ophthalmic Surgical Systems by Type, AP & ROW Market Forecast, 2009-2017 Exhibit 6-56: AP & ROW Market Forecast for Phacoemulsification, 2009-2017 Exhibit 6-57: AP & ROW Market Forecast for Phacoemulsification: Systems, Accessories, and Service, 2009-2017 Exhibit 6-58: AP & ROW Market Forecast for Refractive Laser Systems, 2009-2017 Exhibit 6-59: AP & ROW Market Forecast for Refractive Laser Systems: Systems, Accessories, and Service, 2009-2017 Exhibit 6-60: AP & ROW Market Forecast for Licensing Fees Associated with Refractive Laser Systems, 2009-2017 Exhibit 6-61: AP & ROW Market Forecast for Implants and Disposables by Type, 2009-2017 Exhibit 6-62: AP & ROW Market Forecast for Cataract IOLs, 2009-2017 Exhibit 6-63: AP & ROW Market Forecast for Ophthalmic Viscosurgical Devices, 2009-2017 Exhibit 6-64: AP & ROW Market Forecast for Phakic IOLs, 2009-2017 Exhibit 6-65: AP & ROW Market Forecast for Diagnostic Ophthalmic Systems, 2009-2017 Exhibit 6-66: OUS Supplier Shares for Cataract IOLs, 2011 and 2012 Exhibit 6-67: OUS Supplier Shares for Other Cataract Surgical Products, 2011 and 2012 Exhibit 6-68: OUS Supplier Shares for Refractive Surgery Products, 2011 and 2012 Exhibit 6-69: OUS Supplier Shares for Ophthalmic Diagnostic Systems, 2011 and 2012 7. COMPANY PROFILES 7.1 Abbott Medical Optics 7.2 Accutome 7.3 Alcon 7.4 Bausch & Lomb 7.5 Carl Zeiss Meditec 7.6 Dutch Ophthalmic Research Center (DORC) International BV 7.7 Ellex 7.8 Haag-Streit AG 7.9 Iridex Corporation 7.10 LensAR 7.11 Lumenis Vision 7.12 Nidek Company, Ltd. 7.13 Oertli Instruments AG 7.14 Ophtec BV 7.15 Optimedica 7.16 Quantel Medical 7.17 Staar Surgical 7.18 Technolas Perfect Vision 7.19 Topcon Medical Systems 7.20 Ziemer Ophthalmic Systems AG